 | • レポートコード：MRC23Q36694 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（2-3日） • 産業分類：医薬品 |
| Single User | ￥429,200 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥858,400 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界の注射用ベンダムスチン塩酸塩市場について調査・分析し、世界の注射用ベンダムスチン塩酸塩市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（25mg/個、100mg/個）、用途別セグメント分析（病院、診療所、その他）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、Cephalon、Viatris、Apotex、Dr. Reddy's Laboratories、Fresenius Kabi、Baxter、Nang Kuang Pharmaceutical、Chia Tai Tianqing Pharmaceutical、Jiangsu Simcere Pharmaceutical、Yangtze River Pharmaceutical Group、Sichuan Huiyu Pharmaceutical、Kindos Pharmaなどが含まれています。世界の注射用ベンダムスチン塩酸塩市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、注射用ベンダムスチン塩酸塩市場規模を推定する際に考慮しました。本レポートは、注射用ベンダムスチン塩酸塩の世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、注射用ベンダムスチン塩酸塩に関するビジネス上の意思決定に役立てることを目的としています。 ・注射用ベンダムスチン塩酸塩市場の概要 - 製品の定義 - 注射用ベンダムスチン塩酸塩のタイプ別セグメント - 世界の注射用ベンダムスチン塩酸塩市場規模：タイプ別分析（25mg/個、100mg/個） - 注射用ベンダムスチン塩酸塩の用途別セグメント - 世界の注射用ベンダムスチン塩酸塩市場規模：用途別分析（病院、診療所、その他） - 世界の注射用ベンダムスチン塩酸塩市場規模予測（2018年-2029年） - 注射用ベンダムスチン塩酸塩の平均価格推移（2018年-2029年） - 前提条件と制限事項 ・メーカー別競争状況 - メーカー別市場シェア - 世界の主要メーカー、業界ランキング分析 - メーカー別平均価格 - 注射用ベンダムスチン塩酸塩市場の競争状況およびトレンド ・注射用ベンダムスチン塩酸塩の地域別市場規模 - 北米の注射用ベンダムスチン塩酸塩市場規模（2018年-2029年） - アメリカの注射用ベンダムスチン塩酸塩市場規模（2018年-2029年） - ヨーロッパの注射用ベンダムスチン塩酸塩市場規模（2018年-2029年） - アジア太平洋の注射用ベンダムスチン塩酸塩市場規模（2018年-2029年） - 中国の注射用ベンダムスチン塩酸塩市場規模（2018年-2029年） - 日本の注射用ベンダムスチン塩酸塩市場規模（2018年-2029年） - 韓国の注射用ベンダムスチン塩酸塩市場規模（2018年-2029年） - インドの注射用ベンダムスチン塩酸塩市場規模（2018年-2029年） - オーストラリアの注射用ベンダムスチン塩酸塩市場規模（2018年-2029年） - 中南米の注射用ベンダムスチン塩酸塩市場規模（2018年-2029年） - 中東・アフリカの注射用ベンダムスチン塩酸塩市場規模（2018年-2029年） ・タイプ別セグメント：25mg/個、100mg/個 - 世界の注射用ベンダムスチン塩酸塩のタイプ別販売量（2018年-2023年） - 世界の注射用ベンダムスチン塩酸塩のタイプ別売上（2018年-2023年） - 世界の注射用ベンダムスチン塩酸塩のタイプ別価格 ・用途別セグメント：病院、診療所、その他 - 世界の注射用ベンダムスチン塩酸塩の用途別販売量（2018年-2023年） - 世界の注射用ベンダムスチン塩酸塩の用途別売上（2018年-2023年） - 世界の注射用ベンダムスチン塩酸塩の用途別価格 ・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向 Cephalon、Viatris、Apotex、Dr. Reddy's Laboratories、Fresenius Kabi、Baxter、Nang Kuang Pharmaceutical、Chia Tai Tianqing Pharmaceutical、Jiangsu Simcere Pharmaceutical、Yangtze River Pharmaceutical Group、Sichuan Huiyu Pharmaceutical、Kindos Pharma ・産業チェーンと販売チャネルの分析 - 注射用ベンダムスチン塩酸塩産業チェーン分析 - 注射用ベンダムスチン塩酸塩の主要原材料 - 注射用ベンダムスチン塩酸塩の販売チャネル - 注射用ベンダムスチン塩酸塩のディストリビューター - 注射用ベンダムスチン塩酸塩の主要顧客 ・注射用ベンダムスチン塩酸塩市場ダイナミクス - 注射用ベンダムスチン塩酸塩の業界動向 - 注射用ベンダムスチン塩酸塩市場の成長ドライバ、課題、阻害要因 ・調査成果および結論 ・調査方法とデータソース |
Highlights
The global Bendamustine Hydrochloride for Injection market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Bendamustine Hydrochloride for Injection is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Bendamustine Hydrochloride for Injection is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Bendamustine Hydrochloride for Injection include Cephalon, Viatris, Apotex, Dr. Reddy’s Laboratories, Fresenius Kabi, Baxter, Nang Kuang Pharmaceutical, Chia Tai Tianqing Pharmaceutical and Jiangsu Simcere Pharmaceutical, etc. in 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Bendamustine Hydrochloride for Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bendamustine Hydrochloride for Injection.
The Bendamustine Hydrochloride for Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Bendamustine Hydrochloride for Injection market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Bendamustine Hydrochloride for Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Cephalon
Viatris
Apotex
Dr. Reddy’s Laboratories
Fresenius Kabi
Baxter
Nang Kuang Pharmaceutical
Chia Tai Tianqing Pharmaceutical
Jiangsu Simcere Pharmaceutical
Yangtze River Pharmaceutical Group
Sichuan Huiyu Pharmaceutical
Kindos Pharma
Segment by Type
25mg/Pcs
100mg/Pcs
Segment by Application
Hospitals
Clinics
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Bendamustine Hydrochloride for Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Bendamustine Hydrochloride for Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Bendamustine Hydrochloride for Injection Market Overview
1.1 Product Overview and Scope of Bendamustine Hydrochloride for Injection
1.2 Bendamustine Hydrochloride for Injection Segment by Type
1.2.1 Global Bendamustine Hydrochloride for Injection Market Value Comparison by Type (2023-2029)
1.2.2 25mg/Pcs
1.2.3 100mg/Pcs
1.3 Bendamustine Hydrochloride for Injection Segment by Application
1.3.1 Global Bendamustine Hydrochloride for Injection Market Value by Application: (2023-2029)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Bendamustine Hydrochloride for Injection Market Size Estimates and Forecasts
1.4.1 Global Bendamustine Hydrochloride for Injection Revenue 2018-2029
1.4.2 Global Bendamustine Hydrochloride for Injection Sales 2018-2029
1.4.3 Global Bendamustine Hydrochloride for Injection Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Bendamustine Hydrochloride for Injection Market Competition by Manufacturers
2.1 Global Bendamustine Hydrochloride for Injection Sales Market Share by Manufacturers (2018-2023)
2.2 Global Bendamustine Hydrochloride for Injection Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Bendamustine Hydrochloride for Injection Average Price by Manufacturers (2018-2023)
2.4 Global Bendamustine Hydrochloride for Injection Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Bendamustine Hydrochloride for Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Bendamustine Hydrochloride for Injection, Product Type & Application
2.7 Bendamustine Hydrochloride for Injection Market Competitive Situation and Trends
2.7.1 Bendamustine Hydrochloride for Injection Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Bendamustine Hydrochloride for Injection Players Market Share by Revenue
2.7.3 Global Bendamustine Hydrochloride for Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Bendamustine Hydrochloride for Injection Retrospective Market Scenario by Region
3.1 Global Bendamustine Hydrochloride for Injection Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Bendamustine Hydrochloride for Injection Global Bendamustine Hydrochloride for Injection Sales by Region: 2018-2029
3.2.1 Global Bendamustine Hydrochloride for Injection Sales by Region: 2018-2023
3.2.2 Global Bendamustine Hydrochloride for Injection Sales by Region: 2024-2029
3.3 Global Bendamustine Hydrochloride for Injection Global Bendamustine Hydrochloride for Injection Revenue by Region: 2018-2029
3.3.1 Global Bendamustine Hydrochloride for Injection Revenue by Region: 2018-2023
3.3.2 Global Bendamustine Hydrochloride for Injection Revenue by Region: 2024-2029
3.4 North America Bendamustine Hydrochloride for Injection Market Facts & Figures by Country
3.4.1 North America Bendamustine Hydrochloride for Injection Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Bendamustine Hydrochloride for Injection Sales by Country (2018-2029)
3.4.3 North America Bendamustine Hydrochloride for Injection Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Bendamustine Hydrochloride for Injection Market Facts & Figures by Country
3.5.1 Europe Bendamustine Hydrochloride for Injection Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Bendamustine Hydrochloride for Injection Sales by Country (2018-2029)
3.5.3 Europe Bendamustine Hydrochloride for Injection Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Bendamustine Hydrochloride for Injection Market Facts & Figures by Country
3.6.1 Asia Pacific Bendamustine Hydrochloride for Injection Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Bendamustine Hydrochloride for Injection Sales by Country (2018-2029)
3.6.3 Asia Pacific Bendamustine Hydrochloride for Injection Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Bendamustine Hydrochloride for Injection Market Facts & Figures by Country
3.7.1 Latin America Bendamustine Hydrochloride for Injection Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Bendamustine Hydrochloride for Injection Sales by Country (2018-2029)
3.7.3 Latin America Bendamustine Hydrochloride for Injection Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Bendamustine Hydrochloride for Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Bendamustine Hydrochloride for Injection Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Bendamustine Hydrochloride for Injection Sales by Country (2018-2029)
3.8.3 Middle East and Africa Bendamustine Hydrochloride for Injection Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Bendamustine Hydrochloride for Injection Sales by Type (2018-2029)
4.1.1 Global Bendamustine Hydrochloride for Injection Sales by Type (2018-2023)
4.1.2 Global Bendamustine Hydrochloride for Injection Sales by Type (2024-2029)
4.1.3 Global Bendamustine Hydrochloride for Injection Sales Market Share by Type (2018-2029)
4.2 Global Bendamustine Hydrochloride for Injection Revenue by Type (2018-2029)
4.2.1 Global Bendamustine Hydrochloride for Injection Revenue by Type (2018-2023)
4.2.2 Global Bendamustine Hydrochloride for Injection Revenue by Type (2024-2029)
4.2.3 Global Bendamustine Hydrochloride for Injection Revenue Market Share by Type (2018-2029)
4.3 Global Bendamustine Hydrochloride for Injection Price by Type (2018-2029)
5 Segment by Application
5.1 Global Bendamustine Hydrochloride for Injection Sales by Application (2018-2029)
5.1.1 Global Bendamustine Hydrochloride for Injection Sales by Application (2018-2023)
5.1.2 Global Bendamustine Hydrochloride for Injection Sales by Application (2024-2029)
5.1.3 Global Bendamustine Hydrochloride for Injection Sales Market Share by Application (2018-2029)
5.2 Global Bendamustine Hydrochloride for Injection Revenue by Application (2018-2029)
5.2.1 Global Bendamustine Hydrochloride for Injection Revenue by Application (2018-2023)
5.2.2 Global Bendamustine Hydrochloride for Injection Revenue by Application (2024-2029)
5.2.3 Global Bendamustine Hydrochloride for Injection Revenue Market Share by Application (2018-2029)
5.3 Global Bendamustine Hydrochloride for Injection Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Cephalon
6.1.1 Cephalon Corporation Information
6.1.2 Cephalon Description and Business Overview
6.1.3 Cephalon Bendamustine Hydrochloride for Injection Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Cephalon Bendamustine Hydrochloride for Injection Product Portfolio
6.1.5 Cephalon Recent Developments/Updates
6.2 Viatris
6.2.1 Viatris Corporation Information
6.2.2 Viatris Description and Business Overview
6.2.3 Viatris Bendamustine Hydrochloride for Injection Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Viatris Bendamustine Hydrochloride for Injection Product Portfolio
6.2.5 Viatris Recent Developments/Updates
6.3 Apotex
6.3.1 Apotex Corporation Information
6.3.2 Apotex Description and Business Overview
6.3.3 Apotex Bendamustine Hydrochloride for Injection Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Apotex Bendamustine Hydrochloride for Injection Product Portfolio
6.3.5 Apotex Recent Developments/Updates
6.4 Dr. Reddy’s Laboratories
6.4.1 Dr. Reddy’s Laboratories Corporation Information
6.4.2 Dr. Reddy’s Laboratories Description and Business Overview
6.4.3 Dr. Reddy’s Laboratories Bendamustine Hydrochloride for Injection Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Dr. Reddy’s Laboratories Bendamustine Hydrochloride for Injection Product Portfolio
6.4.5 Dr. Reddy’s Laboratories Recent Developments/Updates
6.5 Fresenius Kabi
6.5.1 Fresenius Kabi Corporation Information
6.5.2 Fresenius Kabi Description and Business Overview
6.5.3 Fresenius Kabi Bendamustine Hydrochloride for Injection Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Fresenius Kabi Bendamustine Hydrochloride for Injection Product Portfolio
6.5.5 Fresenius Kabi Recent Developments/Updates
6.6 Baxter
6.6.1 Baxter Corporation Information
6.6.2 Baxter Description and Business Overview
6.6.3 Baxter Bendamustine Hydrochloride for Injection Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Baxter Bendamustine Hydrochloride for Injection Product Portfolio
6.6.5 Baxter Recent Developments/Updates
6.7 Nang Kuang Pharmaceutical
6.6.1 Nang Kuang Pharmaceutical Corporation Information
6.6.2 Nang Kuang Pharmaceutical Description and Business Overview
6.6.3 Nang Kuang Pharmaceutical Bendamustine Hydrochloride for Injection Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Nang Kuang Pharmaceutical Bendamustine Hydrochloride for Injection Product Portfolio
6.7.5 Nang Kuang Pharmaceutical Recent Developments/Updates
6.8 Chia Tai Tianqing Pharmaceutical
6.8.1 Chia Tai Tianqing Pharmaceutical Corporation Information
6.8.2 Chia Tai Tianqing Pharmaceutical Description and Business Overview
6.8.3 Chia Tai Tianqing Pharmaceutical Bendamustine Hydrochloride for Injection Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Chia Tai Tianqing Pharmaceutical Bendamustine Hydrochloride for Injection Product Portfolio
6.8.5 Chia Tai Tianqing Pharmaceutical Recent Developments/Updates
6.9 Jiangsu Simcere Pharmaceutical
6.9.1 Jiangsu Simcere Pharmaceutical Corporation Information
6.9.2 Jiangsu Simcere Pharmaceutical Description and Business Overview
6.9.3 Jiangsu Simcere Pharmaceutical Bendamustine Hydrochloride for Injection Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Jiangsu Simcere Pharmaceutical Bendamustine Hydrochloride for Injection Product Portfolio
6.9.5 Jiangsu Simcere Pharmaceutical Recent Developments/Updates
6.10 Yangtze River Pharmaceutical Group
6.10.1 Yangtze River Pharmaceutical Group Corporation Information
6.10.2 Yangtze River Pharmaceutical Group Description and Business Overview
6.10.3 Yangtze River Pharmaceutical Group Bendamustine Hydrochloride for Injection Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Yangtze River Pharmaceutical Group Bendamustine Hydrochloride for Injection Product Portfolio
6.10.5 Yangtze River Pharmaceutical Group Recent Developments/Updates
6.11 Sichuan Huiyu Pharmaceutical
6.11.1 Sichuan Huiyu Pharmaceutical Corporation Information
6.11.2 Sichuan Huiyu Pharmaceutical Bendamustine Hydrochloride for Injection Description and Business Overview
6.11.3 Sichuan Huiyu Pharmaceutical Bendamustine Hydrochloride for Injection Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Sichuan Huiyu Pharmaceutical Bendamustine Hydrochloride for Injection Product Portfolio
6.11.5 Sichuan Huiyu Pharmaceutical Recent Developments/Updates
6.12 Kindos Pharma
6.12.1 Kindos Pharma Corporation Information
6.12.2 Kindos Pharma Bendamustine Hydrochloride for Injection Description and Business Overview
6.12.3 Kindos Pharma Bendamustine Hydrochloride for Injection Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Kindos Pharma Bendamustine Hydrochloride for Injection Product Portfolio
6.12.5 Kindos Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Bendamustine Hydrochloride for Injection Industry Chain Analysis
7.2 Bendamustine Hydrochloride for Injection Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Bendamustine Hydrochloride for Injection Production Mode & Process
7.4 Bendamustine Hydrochloride for Injection Sales and Marketing
7.4.1 Bendamustine Hydrochloride for Injection Sales Channels
7.4.2 Bendamustine Hydrochloride for Injection Distributors
7.5 Bendamustine Hydrochloride for Injection Customers
8 Bendamustine Hydrochloride for Injection Market Dynamics
8.1 Bendamustine Hydrochloride for Injection Industry Trends
8.2 Bendamustine Hydrochloride for Injection Market Drivers
8.3 Bendamustine Hydrochloride for Injection Market Challenges
8.4 Bendamustine Hydrochloride for Injection Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer